Molecule Details
| InChIKey | MXFWWQICDIZSOA-UHFFFAOYSA-N |
|---|---|
| Canonical SMILES | CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.33 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB11770 |
|---|---|
| Drug Name | Talinolol |
| CAS Number | 57460-41-0 |
| Groups | investigational |
| ATC Codes | C07AB13 |
| Description | Talinolol has been investigated for the basic science of Gastrointestinal Motility Disorder. |
Categories: Adrenergic Agents Adrenergic Antagonists Adrenergic beta-Antagonists Agents causing hyperkalemia Alcohols Amines Amino Alcohols Antiarrhythmic agents Antihypertensive Agents Beta Blocking Agents, Selective Bradycardia-Causing Agents Cardiovascular Agents Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 Substrates Neurotransmitter Agents P-glycoprotein substrates Potential QTc-Prolonging Agents Propanols QTc Prolonging Agents
Cross-references: ChEBI: 135533 CHEMBL152067 ChemSpider: 62014 PubChem:68770 PubChem:347828123 RxCUI: 37546 Wikipedia: Talinolol